122 related articles for article (PubMed ID: 614140)
1. [Fosfomycin. I. Antimicrobial action in vitro].
Carlone NA; Cuffini AM; Cattaneo O
G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
Renzini G; Oliva B
G Ital Chemioter; 1977; 23(2):117-22. PubMed ID: 606610
[No Abstract] [Full Text] [Related]
3. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics].
Grassi GG; Ferrara A; Navone A; Peona V; Sala P
G Ital Chemioter; 1977; 23(2):87-94. PubMed ID: 606614
[No Abstract] [Full Text] [Related]
4. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of fosfomycin].
Giola L; Rizzu D; Zanetti S
G Batteriol Virol Immunol; 1979; 71(1-6):34-40. PubMed ID: 385409
[TBL] [Abstract][Full Text] [Related]
6. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
[TBL] [Abstract][Full Text] [Related]
7. [Fosfomycin, lysine-fosfomycin, arginine-fosfomycin: antibacterial activity in vitro].
Angeretti A; Martinetto P; Valtz A
G Batteriol Virol Immunol; 1980; 73(7-12):272-80. PubMed ID: 6796449
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fosfomycin.
Rodriguez A; Olay T; Oliver LE; Vicente MV
G Ital Chemioter; 1977; 23(2):95-103. PubMed ID: 414954
[No Abstract] [Full Text] [Related]
9. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial potentiality of a new beta-lactum antibiotic fosfomycin.
Dastidar SG; Mazumdar A; Mookerjee M; Chakrabarty AN
Indian J Exp Biol; 1997 Mar; 35(3):300-1. PubMed ID: 9332178
[TBL] [Abstract][Full Text] [Related]
12. Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Albini E; Belluco G; Marca G
Chemioterapia; 1986 Aug; 5(4):268-72. PubMed ID: 3533286
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activity of a halogenated derivative of D-alanine].
Viano I; Santiano M; Savoia D
G Batteriol Virol Immunol; 1979; 72(1-6):134-42. PubMed ID: 121980
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of growth in vitro of bacteria from the oral cavity using a combination of fosfomycin and ampicillin].
Pase U; Tafuro A
G Stomatol Ortognatodonzia; 1984; 3(3):358-60. PubMed ID: 6599001
[No Abstract] [Full Text] [Related]
15. Effects of subinhibitory concentrations of fosfomycin on bacteria.
Lorian V; Atkinson B
G Ital Chemioter; 1977; 23(2):65-74. PubMed ID: 342326
[No Abstract] [Full Text] [Related]
16. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriological aspects of chemoantibiotic therapy with fosfomycin].
Lamanna A; Nicoletti P
Minerva Med; 1978 Dec; 69(59):4061-6. PubMed ID: 740301
[No Abstract] [Full Text] [Related]
18. [Broth microdilution test for the standardized determination of minimal inhibitory and minimal bactericidal concentrations of antimicrobial drugs in rapidly growing aerobic bacteria].
Klare I; Witte W
Z Gesamte Hyg; 1988 Feb; 34(2):111-5. PubMed ID: 3369199
[No Abstract] [Full Text] [Related]
19. [Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1990 May; 36(5):569-75. PubMed ID: 2399858
[TBL] [Abstract][Full Text] [Related]
20. [Action of phosphomycin in vitro (author's transl)].
Langsádl L; Schindler J; Budĕsínský Z
Cesk Epidemiol Mikrobiol Imunol; 1978 Sep; 27(5):289-95. PubMed ID: 152162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
